A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
This report aims to provide a comprehensive presentation of the global market for Adult and Pediatric Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult and Pediatric Vaccines. This report contains market size and forecasts of Adult and Pediatric Vaccines in global, including the following market information:
Global Adult and Pediatric Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Adult and Pediatric Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Adult Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adult and Pediatric Vaccines include GlaxoSmithKline, Sanofi, Merck, Novartis, Pfizer, AstraZeneca, Johnson and Johnson, Takeda Pharmaceutical and Bavarian Nordic, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Adult and Pediatric Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adult and Pediatric Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Adult and Pediatric Vaccines Market Segment Percentages, by Type, 2022 (%)
Adult Vaccines
Pediatric Vaccines
Global Adult and Pediatric Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Adult and Pediatric Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospitals
Medical Care Centers
Others
Global Adult and Pediatric Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Adult and Pediatric Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adult and Pediatric Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Adult and Pediatric Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
Sinovac Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adult and Pediatric Vaccines, market overview.
Chapter 2: Global Adult and Pediatric Vaccines market size in revenue.
Chapter 3: Detailed analysis of Adult and Pediatric Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adult and Pediatric Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Adult and Pediatric Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adult and Pediatric Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adult and Pediatric Vaccines Overall Market Size
2.1 Global Adult and Pediatric Vaccines Market Size: 2022 VS 2029
2.2 Global Adult and Pediatric Vaccines Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adult and Pediatric Vaccines Players in Global Market
3.2 Top Global Adult and Pediatric Vaccines Companies Ranked by Revenue
3.3 Global Adult and Pediatric Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Adult and Pediatric Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Adult and Pediatric Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adult and Pediatric Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Adult and Pediatric Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Adult and Pediatric Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Adult and Pediatric Vaccines Market Size Markets, 2022 & 2029
4.1.2 Adult Vaccines
4.1.3 Pediatric Vaccines
4.2 By Type - Global Adult and Pediatric Vaccines Revenue & Forecasts
4.2.1 By Type - Global Adult and Pediatric Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Adult and Pediatric Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adult and Pediatric Vaccines Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Medical Care Centers
5.1.4 Others
5.2 By Application - Global Adult and Pediatric Vaccines Revenue & Forecasts
5.2.1 By Application - Global Adult and Pediatric Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Adult and Pediatric Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Adult and Pediatric Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Adult and Pediatric Vaccines Revenue & Forecasts
6.2.1 By Region - Global Adult and Pediatric Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Adult and Pediatric Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Adult and Pediatric Vaccines Revenue, 2018-2029
6.3.2 US Adult and Pediatric Vaccines Market Size, 2018-2029
6.3.3 Canada Adult and Pediatric Vaccines Market Size, 2018-2029
6.3.4 Mexico Adult and Pediatric Vaccines Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Adult and Pediatric Vaccines Revenue, 2018-2029
6.4.2 Germany Adult and Pediatric Vaccines Market Size, 2018-2029
6.4.3 France Adult and Pediatric Vaccines Market Size, 2018-2029
6.4.4 U.K. Adult and Pediatric Vaccines Market Size, 2018-2029
6.4.5 Italy Adult and Pediatric Vaccines Market Size, 2018-2029
6.4.6 Russia Adult and Pediatric Vaccines Market Size, 2018-2029
6.4.7 Nordic Countries Adult and Pediatric Vaccines Market Size, 2018-2029
6.4.8 Benelux Adult and Pediatric Vaccines Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Adult and Pediatric Vaccines Revenue, 2018-2029
6.5.2 China Adult and Pediatric Vaccines Market Size, 2018-2029
6.5.3 Japan Adult and Pediatric Vaccines Market Size, 2018-2029
6.5.4 South Korea Adult and Pediatric Vaccines Market Size, 2018-2029
6.5.5 Southeast Asia Adult and Pediatric Vaccines Market Size, 2018-2029
6.5.6 India Adult and Pediatric Vaccines Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Adult and Pediatric Vaccines Revenue, 2018-2029
6.6.2 Brazil Adult and Pediatric Vaccines Market Size, 2018-2029
6.6.3 Argentina Adult and Pediatric Vaccines Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Adult and Pediatric Vaccines Revenue, 2018-2029
6.7.2 Turkey Adult and Pediatric Vaccines Market Size, 2018-2029
6.7.3 Israel Adult and Pediatric Vaccines Market Size, 2018-2029
6.7.4 Saudi Arabia Adult and Pediatric Vaccines Market Size, 2018-2029
6.7.5 UAE Adult and Pediatric Vaccines Market Size, 2018-2029
7 Adult and Pediatric Vaccines Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Adult and Pediatric Vaccines Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Adult and Pediatric Vaccines Major Product Offerings
7.2.4 Sanofi Adult and Pediatric Vaccines Revenue in Global Market (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Adult and Pediatric Vaccines Major Product Offerings
7.3.4 Merck Adult and Pediatric Vaccines Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Adult and Pediatric Vaccines Major Product Offerings
7.4.4 Novartis Adult and Pediatric Vaccines Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Adult and Pediatric Vaccines Major Product Offerings
7.5.4 Pfizer Adult and Pediatric Vaccines Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Adult and Pediatric Vaccines Major Product Offerings
7.6.4 AstraZeneca Adult and Pediatric Vaccines Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Johnson and Johnson
7.7.1 Johnson and Johnson Company Summary
7.7.2 Johnson and Johnson Business Overview
7.7.3 Johnson and Johnson Adult and Pediatric Vaccines Major Product Offerings
7.7.4 Johnson and Johnson Adult and Pediatric Vaccines Revenue in Global Market (2018-2023)
7.7.5 Johnson and Johnson Key News & Latest Developments
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Company Summary
7.8.2 Takeda Pharmaceutical Business Overview
7.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Major Product Offerings
7.8.4 Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue in Global Market (2018-2023)
7.8.5 Takeda Pharmaceutical Key News & Latest Developments
7.9 Bavarian Nordic
7.9.1 Bavarian Nordic Company Summary
7.9.2 Bavarian Nordic Business Overview
7.9.3 Bavarian Nordic Adult and Pediatric Vaccines Major Product Offerings
7.9.4 Bavarian Nordic Adult and Pediatric Vaccines Revenue in Global Market (2018-2023)
7.9.5 Bavarian Nordic Key News & Latest Developments
7.10 LG Life Sciences
7.10.1 LG Life Sciences Company Summary
7.10.2 LG Life Sciences Business Overview
7.10.3 LG Life Sciences Adult and Pediatric Vaccines Major Product Offerings
7.10.4 LG Life Sciences Adult and Pediatric Vaccines Revenue in Global Market (2018-2023)
7.10.5 LG Life Sciences Key News & Latest Developments
7.11 Sinovac Biotech
7.11.1 Sinovac Biotech Company Summary
7.11.2 Sinovac Biotech Business Overview
7.11.3 Sinovac Biotech Adult and Pediatric Vaccines Major Product Offerings
7.11.4 Sinovac Biotech Adult and Pediatric Vaccines Revenue in Global Market (2018-2023)
7.11.5 Sinovac Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Adult and Pediatric Vaccines Market Opportunities & Trends in Global Market
Table 2. Adult and Pediatric Vaccines Market Drivers in Global Market
Table 3. Adult and Pediatric Vaccines Market Restraints in Global Market
Table 4. Key Players of Adult and Pediatric Vaccines in Global Market
Table 5. Top Adult and Pediatric Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Adult and Pediatric Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Adult and Pediatric Vaccines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Adult and Pediatric Vaccines Product Type
Table 9. List of Global Tier 1 Adult and Pediatric Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adult and Pediatric Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Adult and Pediatric Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Adult and Pediatric Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Adult and Pediatric Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Adult and Pediatric Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Adult and Pediatric Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Adult and Pediatric Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Adult and Pediatric Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Adult and Pediatric Vaccines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Adult and Pediatric Vaccines Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Adult and Pediatric Vaccines Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Adult and Pediatric Vaccines Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Adult and Pediatric Vaccines Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Adult and Pediatric Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Adult and Pediatric Vaccines Revenue, (US$, Mn), 2024-2029
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Adult and Pediatric Vaccines Product Offerings
Table 32. GlaxoSmithKline Adult and Pediatric Vaccines Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Adult and Pediatric Vaccines Product Offerings
Table 36. Sanofi Adult and Pediatric Vaccines Revenue (US$, Mn) & (2018-2023)
Table 37. Sanofi Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Adult and Pediatric Vaccines Product Offerings
Table 40. Merck Adult and Pediatric Vaccines Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Adult and Pediatric Vaccines Product Offerings
Table 44. Novartis Adult and Pediatric Vaccines Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Adult and Pediatric Vaccines Product Offerings
Table 48. Pfizer Adult and Pediatric Vaccines Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Adult and Pediatric Vaccines Product Offerings
Table 52. AstraZeneca Adult and Pediatric Vaccines Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Johnson and Johnson Company Summary
Table 55. Johnson and Johnson Adult and Pediatric Vaccines Product Offerings
Table 56. Johnson and Johnson Adult and Pediatric Vaccines Revenue (US$, Mn) & (2018-2023)
Table 57. Johnson and Johnson Key News & Latest Developments
Table 58. Takeda Pharmaceutical Company Summary
Table 59. Takeda Pharmaceutical Adult and Pediatric Vaccines Product Offerings
Table 60. Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue (US$, Mn) & (2018-2023)
Table 61. Takeda Pharmaceutical Key News & Latest Developments
Table 62. Bavarian Nordic Company Summary
Table 63. Bavarian Nordic Adult and Pediatric Vaccines Product Offerings
Table 64. Bavarian Nordic Adult and Pediatric Vaccines Revenue (US$, Mn) & (2018-2023)
Table 65. Bavarian Nordic Key News & Latest Developments
Table 66. LG Life Sciences Company Summary
Table 67. LG Life Sciences Adult and Pediatric Vaccines Product Offerings
Table 68. LG Life Sciences Adult and Pediatric Vaccines Revenue (US$, Mn) & (2018-2023)
Table 69. LG Life Sciences Key News & Latest Developments
Table 70. Sinovac Biotech Company Summary
Table 71. Sinovac Biotech Adult and Pediatric Vaccines Product Offerings
Table 72. Sinovac Biotech Adult and Pediatric Vaccines Revenue (US$, Mn) & (2018-2023)
Table 73. Sinovac Biotech Key News & Latest Developments
List of Figures
Figure 1. Adult and Pediatric Vaccines Segment by Type in 2022
Figure 2. Adult and Pediatric Vaccines Segment by Application in 2022
Figure 3. Global Adult and Pediatric Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Adult and Pediatric Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Adult and Pediatric Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adult and Pediatric Vaccines Revenue in 2022
Figure 8. By Type - Global Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
Figure 9. By Application - Global Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
Figure 10. By Type - Global Adult and Pediatric Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
Figure 12. By Application - Global Adult and Pediatric Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
Figure 14. By Region - Global Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
Figure 15. By Country - North America Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
Figure 16. US Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
Figure 20. Germany Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 21. France Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
Figure 28. China Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. India Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
Figure 34. Brazil Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Adult and Pediatric Vaccines Revenue Market Share, 2018-2029
Figure 37. Turkey Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Adult and Pediatric Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. GlaxoSmithKline Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Johnson and Johnson Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bavarian Nordic Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. LG Life Sciences Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sinovac Biotech Adult and Pediatric Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
